Dolutegravir

Dolutegravir (Tivicay) is a prescription medication used to treat HIV-1 infections. It belongs to a group of medicines known as HIV-1 integrase strand transfer inhibitors. This medicine is used in combination with other HIV medicines to help control HIV infection. Dolutegravir works by blocking an enzyme called integrase, which is needed for HIV to replicate in the body. By blocking this enzyme, the virus cannot multiply, which helps to reduce the amount of HIV in the body and can reduce the risk of HIV-related illnesses. Dolutegravir can also reduce the amount of HIV in the body to undetectable levels when taken in combination with other HIV medicines.

Dolutegravir is an antiviral medication used to treat HIV infection. Here's a breakdown of its key features and how it works:

Function:

  • Dolutegravir belongs to a class of drugs called integrase inhibitors. HIV uses a specific enzyme called integrase to integrate its genetic material into the DNA of human cells. Dolutegravir blocks this enzyme, essentially preventing the virus from replicating and spreading in the body.

Applications:

  • Dolutegravir is used in combination with other antiretroviral medications to:
    • Control HIV infection in adults and children at least 4 weeks old who weigh at least 6.6 lbs (3 kg).
    • In some adults, it can be used with rilpivirine (Edurant) to replace their current HIV medications when certain criteria are met.

Mechanism of Action:

  • As mentioned earlier, dolutegravir targets the integrase enzyme. By inhibiting integrase, it prevents the HIV virus from inserting its genetic material into the DNA of healthy immune system cells. This significantly reduces the ability of the virus to replicate and infect new cells, slowing down HIV progression and improving immune function.

Important Considerations:

  • Dolutegravir is a powerful medication but can cause side effects, including:
    • Headache
    • Nausea
    • Fatigue
    • Sleep problems
    • Abnormal dreams
  • Dolutegravir is typically well-tolerated, but some people may experience a serious side effect called immune reconstitution syndrome (IRIS). This occurs when the immune system starts to recover and attacks weakened or hidden infections.
  • Dolutegravir is a prescription medication and should only be taken under the supervision of a healthcare professional.
  • Dolutegravir is not a cure for HIV, but it can significantly suppress the virus and help people with HIV live long and healthy lives.

If you have any questions about dolutegravir or its use in treating HIV infection, consult a healthcare professional. They can discuss the potential benefits and risks specific to your situation and determine if dolutegravir is the right treatment option for you.

Anatomical Therapeutic Chemical Classification
J - Antiinfectives for systemic use
J05 Antivirals for systemic use
J05A - Direct acting antiviral drugs
J05AJ Integrase inhibitors
Anatomical Therapeutic Chemical Classification
J - Antiinfectives for systemic use
J05 Antivirals for systemic use
J05A - Direct acting antiviral drugs
Anatomical Therapeutic Chemical Classification
J - Antiinfectives for systemic use
J05 Antivirals for systemic use
J05A - Direct acting antiviral drugs
Anatomical Therapeutic Chemical Classification
J - Antiinfectives for systemic use
J05 Antivirals for systemic use
J05A - Direct acting antiviral drugs
Anatomical Therapeutic Chemical Classification
J - Antiinfectives for systemic use
J05 Antivirals for systemic use
J05A - Direct acting antiviral drugs
External Links